Jungbunzlauer, a renowned provider of sustainable ingredients, in collaboration with Professor Karl Wagner from the University of Bonn, has unveiled significant findings from their latest research on tricalcium citrate (TCC TB). This innovative excipient is poised to redefine standards in direct compression for tablet manufacturing within pharmaceutical and nutraceutical sectors.
“Our partnership with Professor Wagner and his team at the Department of Pharmaceutical Technology and Biopharmaceutics emphasizes our dedication to scientific rigor, innovation, and quality,” remarked Markus Gerhart, Senior Director Category Lead Minerals & Solutions at Jungbunzlauer. “Through validated research, we are excited to showcase that our TCC TB not only meets but exceeds expectations in terms of reliability in direct compression, enabling our clients to attain efficiency and quality with confidence.”
Direct compression is gaining popularity due to its effectiveness and compatibility with sensitive ingredients, yet it requires excipients that possess exceptional flow and compactibility. The findings indicate that Jungbunzlauer”s TCC TB excels in flowability, offers strong tablet integrity at low compression forces, and ensures rapid disintegration, even for complex formulations such as minitablets, moisture-sensitive active pharmaceutical ingredients (APIs), and botanical extracts.
Manufactured through the complete neutralization of citric acid with a high-purity calcium source, TCC TB is certified vegan, free from allergens and GMOs, and complies with USP, FCC, and EU standards. These remarkable findings will be showcased at CPHI Global, taking place at Messe Frankfurt (Hall 8, Booth Q55) from October 28 to 30, 2025. Conference participants are encouraged to engage with Jungbunzlauer to discuss the data and discover how TCC TB can effectively address their formulation needs.
Jungbunzlauer has established itself as a leader in the production of high-quality, sustainable ingredients derived from natural sources, catering to various industries, including food and beverage, nutrition, health, and personal care. Committed to developing naturally superior ingredients that enhance everyday life, the company provides a diverse array of texturants, acidulants, sweeteners, and minerals tailored to meet evolving customer demands. With its headquarters in Basel, Switzerland, Jungbunzlauer operates advanced facilities, including extensive fermentation operations across Europe and North America, proudly serving over 130 countries globally. Founded more than 150 years ago, the company has grown into a CHF 1.3 billion enterprise, supported by nearly 1,400 dedicated professionals striving for a healthier, more sustainable future.
For more information, visit www.jungbunzlauer.com.
